Michel de Rosen
||This biography of a living person needs additional citations for verification. (June 2012) (Learn how and when to remove this template message)|
||This article's use of external links may not follow Wikipedia's policies or guidelines. (December 2012) (Learn how and when to remove this template message)|
Michel de Rosen (born February 18, 1951) is the Chairman of Faurecia  and was the CEO of Eutelsat Communications from 2009 to 2016. He is a non-executive member of the board of directors of ABB Ltd. He was Chief Executive Officer and Chairman of the Board of Directors of ViroPharma Incorporated from August 2002 to May 2008. From 1982 to 1999, de Rosen held several positions in Rhone-Poulenc (France) and Rhone-Poulenc Rorer (USA) (now Sanofi-Aventis), including Chief Executive Officer from May 1995 until December 1999, and Chairman of the Board of Directors from 1996 to 1999.
De Rosen is or has been on a number of boards:
- ABB Ltd (director, since 2002);
- Aspen Institute  (mentor)
- Global Business Coalition on HIV/AIDS  (director)
- HTH Worldwide ;(advisor)
- InnaPhase Corporation (director, July 2000 - September 2004)
- Pennsylvania Bio  (director)
- Ursinus College  (trustee)
In an interview with the British newspaper The Sunday Telegraph on 1995-10-08 he was quoted as saying that he ...sees RPR as a mixture of 'hunting' - growing the company by swooping on acquisition 'prey' - and 'farming', less glamorous but vital organic growth and development of new drugs.